Study to Compare GI Tolerability Following Oral Administration of Bafiertam™ or Tecfidera to Healthy Volunteers
Status:
Completed
Trial end date:
2019-10-19
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to compare in healthy subjects, the GI tolerability of
bioequivalent doses of Bafiertam™(monomethyl fumarate) and its pro-drug Tecfidera® (dimethyl
fumarate).
Secondary objective of this study is to compare the safety and tolerability of Bafiertam™ and
Tecfidera® when administered orally following bioequivalent dose regimens in healthy
subjects.